Items where authors include "Twelves, CJ"

Article

Samson, A orcid.org/0000-0002-3081-7850, West, EJ orcid.org/0000-0001-7449-120X, Carmichael, J et al. (27 more authors) (2022) Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients. Cancer Immunology Research, 10 (6). pp. 745-756. ISSN 2326-6066

Walls, GM, Oughton, JB orcid.org/0000-0002-2047-804X, Chalmers, AJ et al. (20 more authors) (2020) CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancer. Clinical and Translational Radiation Oncology, 25. pp. 61-66. ISSN 2405-6308

Jove, M, Spencer, JA, Hubbard, ME et al. (7 more authors) (2019) Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models. Journal of Pharmacology and Experimental Therapeutics, 370 (2). pp. 242-251. ISSN 0022-3565

Samson, A orcid.org/0000-0002-3081-7850, Scott, KJ orcid.org/0000-0002-5790-9579, Taggart, D et al. (36 more authors) (2018) Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Science Translational Medicine, 10 (422). eaam7577. ISSN 1946-6234

Hubbard, ME, Jove, M, Loadman, PM et al. (3 more authors) (2017) Drug delivery in a tumour cord model: a computational simulation. Royal Society Open Science, 4 (5). 170014. ISSN 2054-5703

Rampling, R, Peoples, S, Mulholland, PJ et al. (17 more authors) (2016) A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. Clinical Cancer Research, 22 (19). pp. 4776-4785. ISSN 1078-0432

Gregory, WM, Twelves, CJ, Bell, R et al. (4 more authors) (2016) Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling. Breast Cancer Research and Treatment, 155 (2). pp. 303-311. ISSN 0167-6806

Groh, CM, Hubbard, ME, Jones, PF orcid.org/0000-0001-8144-4436 et al. (6 more authors) (2014) Mathematical and computational models of drug transport in tumours. Journal of the Royal Society Interface, 11 (94). 20131173. ISSN 1742-5689

Brown, SR, Gregory, WM, Twelves, CJ et al. (5 more authors) (2011) Designing phase II trials in cancer: a systematic review and guidance. British Journal of Cancer, 105 (2). 194 - 199 . ISSN 1532-1827

Conference or Workshop Item

Spencer, JA, Race, AD, Cooper, PA et al. (3 more authors) (2020) Abstract 4847: Optimizing the combination of the CDK4/6 inhibitor palbociclib and paclitaxel using cell cycle analysis. In: Proceedings: AACR Annual Meeting 2020, 27-28 Apr 2020, Philadelphia, PA, USA.

Proceedings Paper

Tripathy, D, Tolaney, SM, Seidman, AD et al. (9 more authors) (2018) ATTAIN: Phase III study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). In: Annals of Oncology. 43rd ESMO Congress (ESMO 2018), 19-23 Oct 2018, Munich, Germany. Oxford University Press .

Tripathy, D, Sara, T, Seidman, AD et al. (9 more authors) (2018) ATTAIN: Phase 3 study of etirinotecan pegol (EP) vs treatment of physician's choice (TPC) in patients (pts) with metastatic breast cancer (MBC) who have stable brain metastases (BM) previously treated with an anthracycline, a taxane, and capecitabine (ATC). In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Spears, M, Kalatskaya, I, Trinh, QM et al. (12 more authors) (2018) Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Spears, M, Kornaga, E, Lyttle, N et al. (12 more authors) (2018) Validation that a histone gene signature predicts anthracycline response in early breast cancer. In: Cancer Research. 2017 San Antonio Breast Cancer Symposium, 05-09 Dec 2017, San Antonio, Texas, U.S.A.. American Association for Cancer Research. American Association for Cancer Research .

Tripathy, D, Tolaney, S, Seidman, AD et al. (5 more authors) (2017) Phase 3 study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer who have stable brain metastases previously treated with an anthracycline, a taxane, and capecitabine. In: Cancer Research. 2016 San Antonio Breast Cancer Symposium, 06 Dec 2016 - 10 Dec 2010, San Antonio, Texas, U.S.A.. American Association for Cancer Research .

Jove, M, Loadman, P, Wicks, J et al. (4 more authors) (2016) 5-Fluorouracil (5FU) intratumoural pharmacokinetics: Rapid uptake in cells and in spheroids (SPH). In: Annals of Oncology. 41st ESMO Congress (ESMO 2016), 07-11 Oct 2016, Copenhagen, Denmark. Oxford University Press .